Human immune challenge to assess proof-of-mechanism in drug development
0 citationsOxford University Research Archive (ORA) (University of Oxford)
Philip G. Drennan
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
31Publications signalées
920Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Antibiotics Pharmacokinetics and EfficacyAntimicrobial Resistance in StaphylococcusSARS-CoV-2 and COVID-19 ResearchPneumonia and Respiratory InfectionsCystic Fibrosis Research Advances
Publications récentes
T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination
Ji-Li Chen, Beibei Wang, Yongxu Lu, Elie Antoun et autres
10 citationsNature Communications
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response
Philip G. Drennan, Nicholas M. Provine, Stephanie A. Harris, Ashley Otter et autres
10 citationsThe Lancet Microbe
Systemic antibiotic prophylaxis in arthroplasty – a narrative review of how many doses are optimal
Peter Wahl, Philip G. Drennan, Michel Schläppi, Yvonne Achermann et autres
2 citationsEFORT Open Reviews
Immunogenicity of MVA-BN Vaccine Deployed as Mpox Prophylaxis: A Prospective Cohort Study and Analysis of Transcriptomic Predictors of Response
Philip G. Drennan, Nicholas M. Provine, Stephanie A. Harris, Ashley Otter et autres
1 citationSSRN Electronic Journal
In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review
Philip G. Drennan, Dimitrios Karponis, Duncan Richards, Mark Coles et autres
9 citationsClinical and Translational Science
Assessment of an institutional guideline for vancomycin dosing and identification of predictive factors associated with dose and drug trough levels
Qingze Gu, N. R. Jones, Philip G. Drennan, Tim Peto et autres
12 citationsJournal of Infection
Mycobacterium tuberculosis transmission in Birmingham, UK, 2009–19: An observational study
A Sarah Walker, Marc Choisy, Martin Dedicoat, Philip G. Drennan et autres
26 citationsThe Lancet Regional Health - Europe
Assessment of a vancomycin dosing guideline and identification of predictive factors associated with dose and drug trough levels
Qingze Gu, Nicola Jones, Philip G. Drennan, Tim Peto et autres
0 citationsmedRxiv
Population pharmacokinetics of free flucloxacillin in patients treated with oral flucloxacillin plus probenecid
Philip G. Drennan, Jared K. Green, Sharon J. Gardiner, Sarah Metcalf et autres
9 citationsBritish Journal of Clinical Pharmacology
Bayesian Forecasting for Intravenous Tobramycin Dosing in Adults With Cystic Fibrosis Using One Versus Two Serum Concentrations in a Dosing Interval
Philip G. Drennan, Yann Thoma, Lucinda Barry, Johan Matthey et autres
13 citationsTherapeutic Drug Monitoring
Predictive Performance of Bayesian Vancomycin Monitoring in the Critically Ill*
Sujita W. Narayan, Yann Thoma, Philip G. Drennan, Hannah Yejin Kim et autres
22 citationsCritical Care Medicine
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.